Blackstone Inc’s Pulmonx LUNG Stock Holding History

Blackstone Inc’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44,827	Closed	-$1.98M	–	649
2021 Q2	$1.98M	Buy	44,827 +18,353	+69%	+$799K	﹤0.01%	347
2021 Q1	$1.21M	Buy	+26,474	New	+$1.52M	﹤0.01%	340

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MGM

Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Blackstone Inc's LUNG Position: Q3 2021 in Review

Blackstone Inc sold out of Pulmonx (LUNG) in Q3 2021, closing a stake of 44,827 shares — an estimated $1.98M sold.

Blackstone Inc first reported a position in LUNG in Q1 2021 and held it in 2 quarters. The position peaked at $1.98M in Q2 2021. 120 funds tracked by Wall St. Rank hold LUNG as of Q3 2021.

Blackstone Inc reported no remaining Pulmonx position as of Q3 2021 after selling out during the quarter.
Blackstone Inc sold 44,827 Pulmonx shares in Q3 2021, an estimated $1.98M.
Blackstone Inc first reported a position in Pulmonx in Q1 2021 and held it in 2 quarters.
Blackstone Inc's Pulmonx position peaked at $1.98M in Q2 2021.
120 funds tracked by Wall St. Rank held Pulmonx as of Q3 2021.

Based on Blackstone Inc's 13F filing for Q3 2021, filed 16 Nov 2021.